Featured Moderna Helps Biotech ETFs Mitigate Massive Losses as Stocks Tumble By Ian YoungJanuary 4, 2021
Featured As U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to Rally By Ian YoungDecember 3, 2020
ETF Building Blocks Content Hub How Increased FDA Activity Can Benefit ETFs in Your Portfolio By Tom LydonNovember 19, 2020
Equity ETF Content Hub Biotech ETFs Poised for Gains after Moderna Vaccine News By Ian YoungNovember 16, 2020
ETF Building Blocks Content Hub More than Just COVID: Hot ETFs for Medical Breakthroughs By Tom LydonNovember 5, 2020
Beyond Basic Beta Content Hub Can’t Get Enough Biotech Exposure in Your Portfolio? By Ben HernandezOctober 29, 2020
ETF Building Blocks Content Hub Post-Election Considerations for a Nifty Biotech ETF By Tom LydonOctober 7, 2020
Leveraged & Inverse Content Hub Short Sellers Back Off From Biotech ETFs By Ben HernandezSeptember 28, 2020
Leveraged & Inverse Content Hub Biotech Has Been in a Steady Uptrend Even Through Covid-19 By Ben HernandezAugust 20, 2020
